Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,621 | 43 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $453.40 | 5 | $0 (2021) |
| Astellas Pharma US Inc | $211.35 | 10 | $0 (2022) |
| Janssen Biotech, Inc. | $128.46 | 3 | $0 (2021) |
| HealthTronics Mobile Solutions, LLC | $120.00 | 1 | $0 (2020) |
| BOSTON SCIENTIFIC CORPORATION | $93.31 | 1 | $0 (2021) |
| Medtronic, Inc. | $82.89 | 1 | $0 (2022) |
| Augmenix, Inc. | $73.79 | 2 | $0 (2018) |
| Endocare, Inc. | $71.71 | 1 | $0 (2018) |
| ABBVIE INC. | $53.91 | 2 | $0 (2022) |
| Axonics, Inc. | $51.03 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $78.43 | 4 | IMMUNITYBIO, INC. ($23.50) |
| 2023 | $76.89 | 4 | Axonics, Inc. ($24.14) |
| 2022 | $237.06 | 8 | Medtronic, Inc. ($82.89) |
| 2021 | $158.12 | 6 | BOSTON SCIENTIFIC CORPORATION ($93.31) |
| 2020 | $349.84 | 3 | Bayer HealthCare Pharmaceuticals Inc. ($124.75) |
| 2019 | $237.26 | 8 | Astellas Pharma US Inc ($117.43) |
| 2018 | $362.95 | 8 | Bayer HealthCare Pharmaceuticals Inc. ($117.07) |
| 2017 | $120.04 | 2 | Bayer HealthCare Pharmaceuticals Inc. ($110.39) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Immunotherapy | ||||||
| 09/09/2024 | COLOPLAST CORP | Titan (Device) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Men's Health | ||||||
| 03/13/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2023 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: UROLOGY | ||||||
| 07/28/2023 | Axonics, Inc. | Axonics (Device), Bulkamid | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Urology | ||||||
| 07/20/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: HORMONE THERAPY | ||||||
| 05/24/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 11/02/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/31/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $34.11 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/25/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: ONCOLOGY | ||||||
| 09/28/2022 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: HORMONE THERAPY | ||||||
| 05/25/2022 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 05/18/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Urology | ||||||
| 05/05/2022 | Axonics, Inc. | Bulkamid (Device), Axonics | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: Urology | ||||||
| 04/07/2022 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $82.89 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/18/2021 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Oncology | ||||||
| 11/09/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Oncology | ||||||
| 06/16/2021 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: UROTHELIAL CANCER | ||||||
| 03/31/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: HORMONE THERAPY | ||||||
| 03/01/2021 | Janssen Biotech, Inc. | ERLEADA (Drug), BALVERSA | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: Oncology | ||||||
| 02/09/2021 | BOSTON SCIENTIFIC CORPORATION | GENERAL ERECTILE DYSFUNCTION (Device) | Food and Beverage | In-kind items and services | $93.31 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/25/2020 | Janssen Biotech, Inc. | ERLEADA (Drug), BALVERSA | Food and Beverage | In-kind items and services | $105.09 | General |
| Category: Oncology | ||||||
| 01/24/2020 | HealthTronics Mobile Solutions, LLC | Mobile Cryoblation Services (Device) | Food and Beverage | Cash or cash equivalent | $120.00 | General |
| Category: Cryoblation Probe | ||||||
| 01/23/2020 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $124.75 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 1,366 | 6,119 | $943,323 | $204,669 |
| 2022 | 33 | 1,353 | 9,327 | $1.0M | $246,150 |
| 2021 | 28 | 1,411 | 7,399 | $800,758 | $199,083 |
| 2020 | 25 | 1,163 | 5,614 | $587,518 | $153,735 |
All Medicare Procedures & Services
121 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 17 | 3,540 | $199,320 | $65,449 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 204 | 285 | $88,033 | $26,887 | 30.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 21 | 156 | $184,194 | $21,136 | 11.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 77 | 91 | $62,672 | $17,355 | 27.7% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 44 | 44 | $86,780 | $12,837 | 14.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 79 | 79 | $41,005 | $9,240 | 22.5% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 13 | 13 | $44,439 | $7,467 | 16.8% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 44 | 44 | $37,651 | $6,867 | 18.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 56 | 69 | $14,960 | $5,142 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 51 | $10,813 | $3,479 | 32.2% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 16 | 16 | $11,488 | $3,077 | 26.8% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 23 | 25 | $21,703 | $2,476 | 11.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 22 | 22 | $6,820 | $2,220 | 32.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 34 | $7,765 | $2,130 | 27.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 16 | 16 | $10,976 | $1,814 | 16.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 23 | 44 | $6,285 | $1,723 | 27.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $6,823 | $1,646 | 24.1% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 20 | 24 | $8,176 | $1,633 | 20.0% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 20 | 688 | $5,504 | $1,518 | 27.6% |
| 51705 | Simple change of bladder tube | Office | 2023 | 11 | 17 | $5,674 | $1,345 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 20 | 24 | $3,552 | $1,212 | 34.1% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 44 | 44 | $33,566 | $1,116 | 3.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 19 | 19 | $5,610 | $1,107 | 19.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 21 | $1,680 | $1,049 | 62.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 44 | 81 | $5,044 | $926.55 | 18.4% |
About Dr. Caleb Stepan, M.D
Dr. Caleb Stepan, M.D is a Urology healthcare provider based in Grand Junction, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1023137940.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Caleb Stepan, M.D has received a total of $1,621 in payments from pharmaceutical and medical device companies, with $78.43 received in 2024. These payments were reported across 43 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,621).
As a Medicare-enrolled provider, Stepan has provided services to 5,293 Medicare beneficiaries, totaling 28,459 services with total Medicare billing of $803,638. Data is available for 4 years (2020–2023), covering 121 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Grand Junction, CO
- Active Since 03/29/2007
- Last Updated 01/23/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1023137940
Products in Payments
- Xofigo (Drug) $202.40
- Nubeqa (Drug) $140.61
- ERLEADA (Drug) $128.46
- Mobile Cryoblation Services (Device) $120.00
- Stivarga (Drug) $110.39
- GENERAL ERECTILE DYSFUNCTION (Device) $93.31
- INTERSTIM (Device) $82.89
- SpaceOAR (Device) $73.79
- XTANDI (Drug) $64.02
- MYRBETRIQ (Drug) $60.34
- LUPRON DEPOT (Drug) $53.91
- PYLARIFY (Drug) $48.94
- ORGOVYX (Drug) $48.83
- Erleada (Drug) $34.50
- Bulkamid (Device) $26.89
- Axonics (Device) $24.14
- ANKTIVA (Drug) $23.50
- Prolia (Biological) $20.00
- Titan (Device) $18.24
- MYRISK (Device) $16.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Grand Junction
Timothy Vanadurongvan, M.d, M.D
Urology — Payments: $10,509
Sydney Querfeld
Urology — Payments: $4,488
Zephaniah Quigley, Fnp-C, FNP-C
Urology — Payments: $3,069
Mark Nishiya, Md, MD
Urology — Payments: $2,267
Clifford Wanebo, M.d, M.D
Urology